111’s (YI) Sell (E+) Rating Reaffirmed at Weiss Ratings

111 (NASDAQ:YIGet Free Report)‘s stock had its “sell (e+)” rating reaffirmed by Weiss Ratings in a research note issued to investors on Saturday,Weiss Ratings reports.

111 Price Performance

Shares of 111 stock opened at $6.59 on Friday. 111 has a 1-year low of $4.14 and a 1-year high of $15.80. The company’s fifty day simple moving average is $6.58 and its 200-day simple moving average is $7.74. The stock has a market capitalization of $56.34 million, a PE ratio of -1.65 and a beta of 0.41.

111 (NASDAQ:YIGet Free Report) last posted its earnings results on Wednesday, November 27th. The company reported ($0.20) earnings per share for the quarter.

About 111

(Get Free Report)

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.

Featured Stories

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.